Vernakalant Use in Cardioversion of Recent Onset Atrial Fibrillation: A Case Report
Journal Title: Acta Facultatis Medicae Naissensis - Year 2018, Vol 35, Issue 3
Abstract
Atrial fibrillation (AF) is a chaotic, irregular atrial rhythm at 300-600 bpm. The AV node conducts the impulse intermittently, causing the irregular ventricular rate. The main risk is of embolism (stroke), which is preventable by anticoagulation. The current estimate of the AF prevalence in the developed world is approxi-mately 1.5-2% in the general population, with the average age of patients with this condition steadily rising to between 75 and 85 years. Hospitalization of patients with AF is also very common. Vernakalant (Brinavess®) is a concentrate that is made up into a solution of infusion (drip into a vein). In recent years, vernakalant has emerged as a novel agent for the termination of recent-onset AF. Forty-seven-year-old man felt chest discomfort and palpitations after a strenuous work (lifting heavy objects). After calling the EMS, the patient was transferred to hospital. When more detailed history was taken, it was established that the patient had the diagnosis of paroxysmal AF for which he was taking Concor 1.25 mg q.d. and Simvastatin 40 mg q.d. BP 160/70 mmHg. ECG was done in the emergency room (ER) which revealed AF with rapid ventricular rate of 135 bpm with no ST–T changes. Laboratory analysis showed: pro BNP 89.1 pg/ml, CK 3.8, venous ABG unremarkable. Cardiac ultrasound was unremarkable and the patient was properly anticoagulated with heparin and enoxaparin in order to receive vernakalant. He was treated with vernakalant 3mg/kg i.v. in the ER. Ten minutes afterwards, a repeated ECG was done showing a normal sinus rhythm at 75 bpm. The patient was discharged from hospital in stable condition. Vernakalant was successful in converting recent-onset AF into the sinus rhythm in the emergency department.
Authors and Affiliations
Vuk Niković, Predrag Blagojević, Dušan Milenković, Anton Laggner, Hans Domanovits, Ranka Bulajić
Keywords
Related Articles
- EP ID EP398719
- DOI 10.2478/afmnai-2018-0027
- Views 111
- Downloads 0
OPSESIVNO-KOMPULSIVNI POREMEĆAJ I TRETMAN - JEDNOGODIŠNJA PROSPEKTIVNA STUDIJA
Opsesivno-kompulsivni poremećaj je definisan kroz prisutnost opsesija i/ili kompulsija koji su toliko česti da izazivaju značajan distres. Ličnost sa opsesivno-kompulsivnim poremećajem prepoznaje da su opsesije i kompuls...
Upoređivanje efekata deksmedetomidina i midazolama na sedaciju dece sa povredom glave radi snimanja CT-om na Odeljenju urgentne medicine
Veliki broj dece koja se upućuju na Odeljenje urgentne medicine javlja se zbog povreda glave. Najčešće se deci daju sedativi kako bi se umirila i savladala strah zbog CT snimanja. Deksmedetomidin i Midazolam pripadaju gr...
Contribution to the History of Serbian Medicine: Ten Years from the Introduction of Clostridium Difficile into Microbiological Diagnostics in Serbia - - - Doprinos razvoju medicine u Srbiji: deset godina od uvođenja mikrobiološke dijagnostike Clostridium Difficileu Srbiji
In Serbia, the first isolates of C. difficile were isolated in the Public Health Institute (PHI), Center for Microbiology in Niš, at the end of 2005. The National Reference Laboratory for Anaerobic Infections (NRLA) in P...
NEW FRONTIERS OF TARGET THERAPY IN ONCOLOGY: ACUTE PROMYELOCYTIC LEUKEMIA
By introduction of all-trans retinoic acid (ATRA) in de novo acute promyelocytic leukemia (APL) an revolution in therapy of this disease has been made. The rate of molecular complete remissions (CR) have been doubled com...
VIRUSNI MIOKARDITIS - DIJAGNOSTIČKI I TERAPIJSKI IZAZOV ZA LEKARE
Miokarditis se definiše kao zapaljenje srčanog mišića prema kliničkim, imunohistohemijskim i patološkim kriterijumima. Miokarditis se može manifestovati širokim spektrom simptoma od blage dispneje do bola u grudima, a po...